Navigation path

Additional tools

    Profile of registrant

SFL Regulatory Affairs & Scientific Communication GmbH

Identification number in the register: 31442479070-19
Registration date: 02/07/2012 14:04:35

The information on this entity was last modified on: 06/06/2014 13:41:41
The date of the last annual update was: 06/06/2014 13:41:41

This entry follows the format of the previous Register. It will be changed to the new format when the entity makes the next update.
Next update due latest on: 27/04/2015

    Registrant : Organisation or self-employed individual

SFL Regulatory Affairs & Scientific Communication GmbH


GmbH (Ltd liab. Co.)

    Section of registration

I - Professional consultancies/law firms/self-employed consultants

Professional consultancies

    Contact details

Schillerstrasse 7
Basel 4053

(+41) 61 366 71 61

(+41) 61 361 94 42

    Person with legal responsibility

Ms  Shayesteh Fürst-Ladani

Managing Director

    Person in charge of EU relations

Ms  Anna Hallersten

Public Affairs Director

    Goals / remit

SFL Regulatory Affairs & Scientific Communication Ltd (SFL) is a multi-national team with extensive experience in the pharmaceutical as well as medtech industries.

SFL’s core competencies are:
• Regulatory Affairs
• Public Affairs
• Legal Services
• Medical Communication

This enables us to understand and meet clients’ needs through every stage of the product lifecycle. Each team member has a proven track record in specific areas of expertise and an excellent understanding of the interconnectedness of the different stages and functions of the lifecycle of a product.

Public Affairs Services
SFL advises organizations on how to engage in the EU debate to shape healthcare policies and regulatory frameworks. Our team has extensive hands-on experience and proven success in contributing to EU healthcare laws and policies. SFL's public affairs team has worked in functions inside the industry as well as in the public sector. Our public affairs services comprise:
EU political intelligence (monitoring, impact analysis of coming/changing laws and policies, news updates tailored to client needs)
Engagement strategy (stakeholder mapping, strategic partnerships, working with industry associations, step-by-step plans to address policy and regulatory matters, support with drafting communication materials, coordination of workshops and debates)
Capacity building (training on Eu institutions and legislative processes, public affairs methods and tools, lobbying codes, advice on internal organizational matters to help clients formulate aligned positions and speak with one voice to regulators and policy-makers)

The SFL team works from offices in Switzerland and the United Kingdom, Europe’s key locations for healthcare product development. We support our clients by offering personalized and comprehensive services which, when combined, provide an integrated solution for products from the bench to the marketplace within one consultancy.
SFL offers expertise in the following product classes - drugs, medical devices, in vitro diagnostics, combination products, and ATMPs - and in a broad range of therapeutic areas.

SFL is an associate member of EuropaBio.



Drafting and review of industry communication materials relating to key healthcare policy and legislative dossiers under revision by the EU institutions

    Number of persons involved in the activities described in the box above


    Persons accredited for access to European Parliament premises

No accredited persons

    Fields of interest

  • Competition
  • Consumer Affairs
  • Enterprise
  • Food Safety
  • General and Institutional Affairs
  • Internal Market
  • Public Health
  • Research and Technology

    Membership and affiliation

SFL is an associate member of EuropaBio

SFL is a member of the Drug Information Association (DIA)

SFL is member of The Organisation for Professionals in Regulatory Affairs (TOPRA)

SFL is a member of SwAPP

SFL is a member of Biovalley Basel - the Life Sciences Network

SFL is a member of the British-Swiss Chamber of Commerce

    Financial data

01/2013  -  12/2013

300,000  € - 350,000  €

  • Nobel Biocare
  • Merck Serono
  • Novartis
  • Roche

0 €

0 €

    Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.